Sunshine Biopharma SBFM
NASDAQ SBFM
$0.67 -0.02 (-2.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sunshine Biopharma (SBFM) Interest & Investment Income (2021 - 2026)

Updated

Sunshine Biopharma (SBFM) reported Interest & Investment Income of $48,816 for Q2 2026, down 32.9% from $72,715 a year earlier.

Analysis

Sunshine Biopharma (SBFM) Interest & Investment Income (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Sunshine Biopharma's Interest & Investment Income came in at $121,533; for FY2020, it came in at $2,836, up 107.5% from FY2019.

  • By year, Interest & Investment Income came in at $1,367 in FY2019.
  • The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Sunshine Biopharma 914,767.10 -38.18 Mn 2.43 Mn 48,816.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48,816.00
Jun 30, 2025 72,715.00
Jun 30, 2021 2.00
API Access

Sunshine Biopharma Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SBFM&period=max&api_key=YOUR_API_KEY